CINECA IRIS Institutional Research Information System

MIGLIARDI, GIORGIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.416
EU - Europa 1.362
AS - Asia 1.277
OC - Oceania 88
SA - Sud America 52
AF - Africa 25
Continente sconosciuto - Info sul continente non disponibili 2
Totale 4.222
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.326
CN - Cina 633
GB - Regno Unito 306
IT - Italia 306
DE - Germania 253
JP - Giappone 130
IN - India 126
FR - Francia 85
AU - Australia 78
CA - Canada 71
HK - Hong Kong 70
NL - Olanda 64
ES - Italia 54
KR - Corea 47
RU - Federazione Russa 40
CZ - Repubblica Ceca 36
TR - Turchia 33
PK - Pakistan 30
SG - Singapore 29
BR - Brasile 28
IE - Irlanda 28
TW - Taiwan 27
VN - Vietnam 26
CH - Svizzera 24
HU - Ungheria 24
PL - Polonia 21
ID - Indonesia 18
MX - Messico 16
IL - Israele 15
PT - Portogallo 15
BE - Belgio 14
IR - Iran 14
RO - Romania 14
MY - Malesia 13
SE - Svezia 13
ZA - Sudafrica 13
DK - Danimarca 11
MO - Macao, regione amministrativa speciale della Cina 11
SA - Arabia Saudita 11
CO - Colombia 10
NZ - Nuova Zelanda 10
UA - Ucraina 10
SI - Slovenia 9
PH - Filippine 8
AT - Austria 7
CY - Cipro 7
FI - Finlandia 7
TH - Thailandia 7
BD - Bangladesh 5
EE - Estonia 5
JO - Giordania 5
UZ - Uzbekistan 5
AR - Argentina 4
CL - Cile 4
MT - Malta 4
NO - Norvegia 4
EG - Egitto 3
GR - Grecia 3
LU - Lussemburgo 3
NG - Nigeria 3
AE - Emirati Arabi Uniti 2
BO - Bolivia 2
EU - Europa 2
PE - Perù 2
PY - Paraguay 2
QA - Qatar 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
TZ - Tanzania 2
DZ - Algeria 1
HR - Croazia 1
KE - Kenya 1
LB - Libano 1
LK - Sri Lanka 1
MN - Mongolia 1
PR - Porto Rico 1
RS - Serbia 1
Totale 4.222
Salva come PNG Salva come JPEG
Città #
Beijing 124
Shanghai 83
Houston 62
Fairfield 59
Cambridge 44
Ann Arbor 43
Torino 42
Tokyo 40
Ashburn 37
Seattle 37
Santa Cruz 35
Woodbridge 35
Hangzhou 34
Nanjing 34
New York 34
London 32
Guangzhou 31
Central 26
Wilmington 26
Wuhan 25
Changsha 23
Sutton Coldfield 23
Chengdu 21
Los Angeles 21
Taipei 21
Mumbai 20
Central District 19
Dong Ket 19
Jinan 19
Milan 18
San Diego 18
Seoul 18
Brisbane 17
Singapore 17
Buffalo 16
Carrara 16
Jakarta 15
Boston 14
Nürnberg 14
Toronto 14
San Francisco 13
Turin 13
Chicago 12
Duncan 11
Ottawa 11
San Jose 11
University Park 11
Barcelona 10
Council Bluffs 10
Istanbul 10
Paris 10
Redmond 10
Xian 10
Ahmedabad 9
Ankara 9
Kolkata 9
Lake Forest 9
Ljubljana 9
Mountain View 9
Polska 9
Rome 9
Utrecht 9
Atlanta 8
Bengaluru 8
Chennai 8
Dallas 8
Fremont 8
New Haven 8
Norwalk 8
Trémuson 8
Vancouver 8
Bangalore 7
Brookline 7
Chongqing 7
Dublin 7
Heidelberg 7
Indianapolis 7
Melbourne 7
Oxford 7
Philadelphia 7
Southampton 7
São Paulo 7
Zurich 7
Durham 6
Ettlingen 6
Minneapolis 6
Muizenberg 6
Penicuik 6
Quincy 6
Raleigh 6
Rennes 6
Shenyang 6
Somerville 6
Zhengzhou 6
Baotou 5
Birmingham 5
Bologna 5
Brooklyn 5
Brussels 5
Clearwater 5
Totale 1.721
Salva come PNG Salva come JPEG
Nome #
Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens., file e27ce42e-c849-2581-e053-d805fe0acbaa 2.814
Colorectal cancer residual disease at maximal response to EGFR blockade displays a druggable Paneth cell–like phenotype, file e27ce430-1c84-2581-e053-d805fe0acbaa 475
A molecularly annotated platform of patient-derived xenografts (‘xenopatients’) identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer, file e27ce426-de44-2581-e053-d805fe0acbaa 165
C-met inhibition blocks bone metastasis development induced by renal cancer stem cells, file e27ce428-f46b-2581-e053-d805fe0acbaa 157
IGF2 is an actionable target that identifies a distinct subpopulation of colorectal cancer patients with marginal response to anti-EGFR therapies., file e27ce428-9ce4-2581-e053-d805fe0acbaa 153
Combined blockade of MEK and PI3KCA as an effective antitumor strategy in HER2 gene amplified human colorectal cancer models, file e27ce42e-c6ae-2581-e053-d805fe0acbaa 153
INHIBITION OF MEK AND PI3K/MTOR SUPPRESSES TUMOR GROWTH BUT DOES NOT CAUSE TUMOR REGRESSION IN PATIENT-DERIVED XENOGRAFTS OF RAS-MUTANT COLORECTAL CARCINOMAS, file e27ce426-d43e-2581-e053-d805fe0acbaa 144
The genomic landscape of response to EGFR blockade in colorectal cancer, file e27ce428-9746-2581-e053-d805fe0acbaa 89
Efficacy of NEDD8 Pathway Inhibition in Preclinical Models of Poorly Differentiated, Clinically Aggressive Colorectal Cancer, file e27ce42a-bea3-2581-e053-d805fe0acbaa 48
Efficacy of NEDD8 Pathway Inhibition in Preclinical Models of Poorly Differentiated, Clinically Aggressive Colorectal Cancer, file e27ce42b-0741-2581-e053-d805fe0acbaa 42
Met signaling regulates growth, repopulating potential and basal cell-fate commitment of mammary luminal progenitors: implications for basal-like breast cancer., file e27ce426-cf0f-2581-e053-d805fe0acbaa 39
Sustained Inhibition of HER3 and EGFR Is Necessary to Induce Regression of HER2-Amplified Gastrointestinal Carcinomas, file e27ce428-973d-2581-e053-d805fe0acbaa 33
Amplification of the MET Receptor Drives Resistance to Anti-EGFR Therapies in Colorectal Cancer., file e27ce426-e096-2581-e053-d805fe0acbaa 22
Case report: Preclinical efficacy of NEDD8 and proteasome inhibitors in patient-derived models of signet ring high-grade mucinous colorectal cancer from a Lynch syndrome patient, file d82de37f-401b-46a4-8b57-899917d6fc66 7
IGF2 is an actionable target that identifies a distinct subpopulation of colorectal cancer patients with marginal response to anti-EGFR therapies., file e27ce426-9d2c-2581-e053-d805fe0acbaa 4
Phosphoproteomics of patient-derived xenographs identifies targets and markers associated with sensitivity and resistance to EGFR blockade in colorectal cancer, file d7250c76-5d9e-47fb-9c4d-d8fb5de802ca 3
HER2 Activating Mutations Are Targets for Colorectal Cancer Treatment, file e27ce427-4ee1-2581-e053-d805fe0acbaa 3
Efficacy of NEDD8 Pathway Inhibition in Preclinical Models of Poorly Differentiated, Clinically Aggressive Colorectal Cancer, file e27ce42a-e1bf-2581-e053-d805fe0acbaa 3
Granulocyte-colony stimulating factor upregulates ErbB2 expression on breast cancer cell lines and converts primary resistance to trastuzumab, file e27ce426-b4e5-2581-e053-d805fe0acbaa 2
Efficient transcriptional targeting of human hematopoietic stem cells and blood cell lineages by lentiviral vectors containing the regulatory element of the Wiskott-Aldrich Syndrome gene, file e27ce426-b4f4-2581-e053-d805fe0acbaa 2
Sustained Inhibition of HER3 and EGFR Is Necessary to Induce Regression of HER2-Amplified Gastrointestinal Carcinomas, file e27ce428-a1a3-2581-e053-d805fe0acbaa 2
Met signaling regulates growth, repopulating potential and basal cell-fate commitment of mammary luminal progenitors: implications for basal-like breast cancer., file e27ce426-cf0e-2581-e053-d805fe0acbaa 1
Antitumor activity of Src inhibitor Saracatinib (AZD-0530) in preclinical models of biliary tract carcinomas., file e27ce426-d2da-2581-e053-d805fe0acbaa 1
A molecularly annotated platform of patient-derived xenografts (‘xenopatients’) identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer, file e27ce426-de43-2581-e053-d805fe0acbaa 1
Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens., file e27ce432-553b-2581-e053-d805fe0acbaa 1
Totale 4.364
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.261
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.261
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201954 0 0 0 0 0 0 0 0 0 11 20 23
2019/2020591 9 10 9 13 15 20 37 78 112 117 82 89
2020/20211.582 64 133 214 184 196 173 175 67 102 85 69 120
2021/20221.014 103 84 98 84 84 67 89 93 101 72 84 55
2022/2023816 59 71 86 117 101 75 62 94 64 56 30 1
2023/202429 3 3 3 1 2 2 3 7 5 0 0 0
Totale 4.364